The global prevalence of Huntington's disease: a systematic review and discussion
- 1 August 2016
- journal article
- research article
- Published by Future Medicine Ltd in Neurodegenerative Disease Management
- Vol. 6 (4), 331-343
- https://doi.org/10.2217/nmt-2016-0008
Abstract
The ascertained prevalence of Huntington's disease (HD) increased significantly following the provision of diagnostic testing. A systematic review was conducted to estimate the prevalence of HD in the post-diagnostic testing era. 22 studies with original data pertaining to the prevalence of HD (1993–2015) were included and analyzed. A global meta-analysis was not performed due to heterogeneity in study methods and geographical variation. The prevalence of HD is significantly lower in Asian populations compared with western Europe, North America and Australia. The global variation in HD prevalence is partly explained by the average CAG repeat lengths and frequency of different HTT gene haplotypes in the general population. Understanding the prevalence of HD has significant implications for healthcare resource planning.Keywords
This publication has 53 references indexed in Scilit:
- Epidemiological Survey-Based Formulae to Approximate Incidence and Prevalence of Neurological Disorders in the United States: a Meta-AnalysisPLOS ONE, 2013
- Juvenile Huntington's disease: a population-based study using the General Practice Research DatabaseBMJ Open, 2013
- Prevalence of adult Huntington's disease in the UK based on diagnoses recorded in general practice recordsJournal of Neurology, Neurosurgery & Psychiatry, 2013
- The Prevalence of Juvenile Huntington's Disease: A Review of the Literature and Meta-AnalysisPLoS Currents, 2012
- HTT haplotypes contribute to differences in Huntington disease prevalence between Europe and East AsiaEuropean Journal of Human Genetics, 2011
- A Systematic Review of the Incidence and Prevalence of Long-Term Neurological Conditions in the UKNeuroepidemiology, 2010
- CAG Expansion in the Huntington Disease Gene Is Associated with a Specific and Targetable Predisposing HaplogroupAmerican Journal of Human Genetics, 2009
- Decreasing uptake of predictive testing for Huntington's disease in a German centre: 12 years' experience (1993–2004)European Journal of Human Genetics, 2008
- Problems assessing uptake of Huntington disease predictive testing and a proposed solutionEuropean Journal of Human Genetics, 2008
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986